# Safety of UFRJvac, Trivalent COVID-19 Vaccine

> **NCT06303635** · — · UNKNOWN · sponsor: **Azidus Brasil** · enrollment: 156 (estimated)

## Conditions studied

- Healthy People

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06303635
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-06-24
- **Primary completion:** 2025-10-16
- **Final completion:** 2025-11-25
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2024-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06303635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06303635, "Safety of UFRJvac, Trivalent COVID-19 Vaccine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06303635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*